ライフサイエンスコーパス: superior mesenteric vein

1 state exogenous insulin replacement into the superior mesenteric vein.

2 venous outflow by a proximal segment of the superior mesenteric vein.

3 uation of tumor, normal pancreas, aorta, and superior mesenteric vein.

4 or mesenteric artery and a catheter into the superior mesenteric vein.

5 one patient with a stent extending into the superior mesenteric vein.

6 igrated to the confluence of the splenic and superior mesenteric veins.

7 the primary tumor (98%), portal vein (97%), superior mesenteric vein (94%), hepatic artery (93%), an

8 vascular invasion, and flow artifacts in the superior mesenteric vein and measured attenuation of tum

9 Computerized tomographic scan showed superior mesenteric vein and portal vein thrombosis.

10 umen area, and diameter of main portal vein, superior mesenteric vein, and splenic vein.

11 (50%) of third-order branching; 17 (85%) in superior mesenteric veins; and 17 (85%) in portal veins.

12 distally at the tail of the pancreas and the superior mesenteric vein at the level of the mesentery o

13 w artifacts and decreased attenuation in the superior mesenteric vein, compared with the artifacts re

14 cm in size with abutment of the portal vein-superior mesenteric vein confluence for less than 180 de

15 more likely to have a difficult portal vein/superior mesenteric vein dissection when compared to the

16 , splenic vein (three of four patients), and superior mesenteric vein (five of five patients).

17 Superior mesenteric vein flow increased from 119 +/- 66

18 or mesenteric artery and a catheter into the superior mesenteric vein in 21 female pigs.

19 el of resection was at or to the left of the superior mesenteric vein in 96% of patients.

20 or beyond the confluence of the splenic and superior mesenteric veins in 21 (60%) and 11 (31%) patie

21 Twenty-two of 25 superior mesenteric vein, main portal vein, and right an

22 the inferior vena cava (n = 10), portal and superior mesenteric veins (n = 7), splenic vein (n = 4),

23 Tumor adherence to the superior mesenteric vein or SMPV confluence was assessed

24 lation of the portal vein (PV) or portal and superior mesenteric veins (PMV) or sham operation (contr

25 coduodenectomy (PD) with en-bloc portal vein/superior mesenteric vein (PV/SMV) resection is used in p

26 e of an allograft superior mesenteric artery-superior mesenteric vein (SMA-SMV) AVF in a pancreas-aft

27 sts also evaluated images for two new signs, superior mesenteric vein (SMV) "beaking" and "criss-cros

28 est and smallest axes (r = -0.39), change in superior mesenteric vein (SMV) and/or portal vein (herea

29 l vein into the liver and atypically located superior mesenteric vein (SMV) joining with the splenic

30 ved lymph nodes, four patients; and need for superior mesenteric vein (SMV) resection, four patients)

31 the gastrojejunostomy line in two patients, superior mesenteric vein (SMV) thrombosis in two patient

32 visualized in 37; splenic vein (SV), in 37; superior mesenteric vein (SMV), in 37; inferior mesenter

33 k velocity measurements were obtained in the superior mesenteric vein (SMV), splenic vein (SV), porta

34 ed across the aorta above the coeliac trunk, superior mesenteric vein, splenic vein and portal vein (

35 nk, superior mesenteric artery, portal vein, superior mesenteric vein, splenic vein, hepatic veins, a

36 One patient had stent migration to the superior mesenteric vein that was removed at the time of

37 teric artery thromboembolism, 25 (22%) had a superior mesenteric vein thrombosis, and 4 (3%) had supe

38 One patient had an isolated superior mesenteric vein thrombus.

39 cal vein, while one had flow reversal in the superior mesenteric vein visible at MR imaging only.